Both fingolimod and ocrelizumab are FDA approved for treatment in adult multiple sclerosis. Only fingolimod is approved for treatment in POMS. This retrospective study explores the safety and efficacy of fingolimod & ocrelizumab in treatment of POMS

🔗 https://buff.ly/i9f90pA